Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03159689
Other study ID # 17-000361
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2018
Est. completion date December 30, 2020

Study information

Verified date April 2021
Source University of California, Los Angeles
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The results from this study may help to explain if incorporating mixed nuts in a reduced calorie diet will lead to weight loss.


Description:

This study will compare two energy reduced diets; one diet will include one serving of mixed nuts (1.5oz) per day, while the other diet will include an equal amount of calories from a carbohydrate source, such as a pretzel snack. All subjects will receive a dietary plan that reduces their usual intake by 500kcal/day with the same percentage of fat, protein and carbohydrates for the first 12 weeks followed a diet with their usual intake for 12 weeks without nuts or pretzels.


Recruitment information / eligibility

Status Completed
Enrollment 131
Est. completion date December 30, 2020
Est. primary completion date December 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 60 Years
Eligibility Inclusion Criteria: - Male or female between the ages of 40-60 years of age (female premenopausal). - Body Mass Index (BMI) 27.0-35.0 kg/m2. - Not currently taking a prescription or over the counter medication for weight loss. - Not currently enrolled in any commercial weight loss program (e.g. Jenny Craig, Weight Watchers), internet based weight-management program, self-help group (e.g. Overeaters Anonymous) or participating in any food preparation/delivery program. If subject is willing to discontinue program immediately and willing to refrain from program for duration of study, he/she may be included after a two-week washout period. - Willing to keep and turn in a daily log/compliance book as required by study protocol. - Willingness and ability to make all scheduled appointments. - Willing to follow dietary recommendations required by study protocol. - Willingness to periodically have small blood samples drawn as indicated in the protocol. Exclusion Criteria: - More than a 5-pound weight gain or weight loss within the 3 months prior to enrollment in the study. - History of thyroid disease, but not taking medication or medication dosage changed one or more times over last 6 months. History of thyroid disease and on a stable dose of prescription medication for 6 months or longer is acceptable. - History of Type I or Type II diabetes, major surgery, heart problems (e.g. angina, bypass surgery, MI, etc.), presence of implanted cardiac defibrillator or pacemaker, uncontrolled hypertension/high blood pressure, gastrointestinal disorders including chronic malabsorptive conditions, peptic ulcer disease, Crohn's disease, chronic diarrhea or active gallbladder disease, inflammatory bowel disease, fatty liver or cancer within three months of enrollment - History of a surgical procedure for weight loss at any time (e.g. gastroplasty, gastric by-pass, gastrectomy or partial gastrectomy). - Following a diet that requires the elimination of FODMAPS (Fermentable Oligosaccharides, Disaccharides, Monosaccharides And Polyols) - Following a specific diet that restricts specific food groups (eg. Paleo) or with extreme macronutrient ratios (carbohydrates, fats and proteins). - History of clinically diagnosed eating disorders including anorexia nervosa, bulimia nervosa or binge eating disorder. - Women who are pregnant, lactating or trying to become pregnant. - Currently taking any prescription medication for less than 3 months. - Currently taking any prescriptions drugs or supplements that may impact weight regulation - Currently consuming >14 alcoholic drinks (1 drink = 12 fl oz beer, 4 fl oz wine or 1.5 fl oz liquor) per week and/or unwilling to limit intake to less than 3 drinks per week during study participation or history of alcohol dependency. - Known allergy to almond, pistachio, walnut, macadamia, cashews, hazelnuts, or pecan nuts. - Participation in another clinical trial within 30 days prior to enrollment. - Currently smoking cigarettes. - Any known clinically significant food allergy or intolerance.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Mixed Tree Nuts
Individuals on a hypo caloric weight loss dietary plan supplemented with 1.5oz mixed tree nuts
Pretzels
Individuals on a hypo caloric weight loss dietary plan supplemented with 1.5oz pretzels

Locations

Country Name City State
United States UCLA Center for Human Nutrition, 900 Veteran Avenue, WH 14-187 Los Angeles California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in body weight Weight loss as determined by body composition and body mass index baseline to Week 24
See also
  Status Clinical Trial Phase
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Terminated NCT03299881 - Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss N/A
Completed NCT02805478 - Fat-Associated Cardiovascular Organ Dysfunction
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Completed NCT03759743 - Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject N/A
Completed NCT03610958 - Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss. N/A
Completed NCT03678766 - CHARGE: Controlling Hunger and ReGulating Eating N/A
Completed NCT04430465 - Effects of Wholegrains on Children's Health (KORN) N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT05376865 - Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers N/A
Completed NCT03625427 - Effect of Palmitoleic Acid on C-reactive Protein N/A
Active, not recruiting NCT03435445 - Online Platform for Healthy Weight Loss (POEmaS) N/A
Enrolling by invitation NCT05576116 - Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics N/A
Recruiting NCT05249465 - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention N/A
Active, not recruiting NCT06023095 - A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities Phase 1
Completed NCT03648892 - Brain Dopamine Function in Human Obesity Early Phase 1
Not yet recruiting NCT05751993 - Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions N/A
Recruiting NCT02887950 - Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause N/A
Terminated NCT02743598 - Liraglutide for HIV-associated Neurocognitive Disorder Phase 4
Completed NCT02829229 - Community-based Obesity Treatment in African American Women After Childbirth N/A